Jeffrey M. Jonas, See Remarks at Sage Therapeutics, Inc. (SAGE), sold 198,600 shares at $78.88 ($15.4M) on 2015-06-15, disclosed to the SEC on 2015-06-17.
Scheduled sale ($15.4M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.22 | 11,329 | $886K | 5.8% |
| 2 | $78.88 | 62,364 | $4.9M | 32.0% |
| 3 | $79.97 | 5,707 | $456K | 3.0% |
| 4 | $81.51 | 2,420 | $197K | 1.3% |
| 5 | $83.89 | 1,554 | $130K | 0.8% |
| 6 | $75.51 | 29,303 |
| $2.2M |
| 14.4% |
| 7 | $76.09 | 64,973 | $4.9M | 32.2% |
| 8 | $76.85 | 14,146 | $1.1M | 7.1% |
| 9 | $78.13 | 6,804 | $532K | 3.5% |
| Total | $77.36 avg | 198,600 | $15.4M | 100% |
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |